M&A Deal Summary |
|
|---|---|
| Date | 2021-07-19 |
| Target | Kite Pharma - Neoantigen TCR Cell Therapy R&D Platform & Manufacturing Facility |
| Sector | Life Science |
| Buyer(s) | BioNTech |
| Sellers(s) | Kite Pharma |
| Deal Type | Divestiture |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Company |
|---|---|
| Founded | 2008 |
| Sector | Life Science |
| Employees | 6,133 |
| Revenue | 3.8B EUR (2023) |
BioNTech is a biopharmaceutical company pioneering the development of individualized therapies for cancer and other diseases. The Company combines all building blocks of individualized immunotherapy under one roof – from diagnostics and drug development to manufacturing. Its cutting-edge technologies range from individualized mRNA-based medicines through innovative chimeric antigen receptors and T-cell receptor-based products to novel checkpoint immunomodulators. BioNTech founded in 2008 and is based in Mainz, Germany.
| DEAL STATS | # |
|---|---|
| Overall | 3 of 4 |
| Sector (Life Science) | 3 of 3 |
| Type (Divestiture) | 2 of 2 |
| State (Maryland) | 1 of 1 |
| Country (United States) | 2 of 2 |
| Year (2021) | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2020-01-16 |
Neon Therapeutics
Cambridge, Massachusetts, United States Neon Therapeutics, Inc. is a biotechnology company developing novel neoantigen-targeted T cell therapies, dedicated to transforming the treatment of cancer by directing the immune system towards neoantigens. Neon is using its neoantigen platform to develop both personal and precision neoantigen-targeted T cell therapy candidates. Neon’s most advanced program is NEO-PTC-01, its personalized neoantigen-targeted T cell therapy candidate consisting of multiple T cell populations targeting the most therapeutically relevant neoantigens from each patient’s tumor. |
Buy | $67M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2023-01-10 |
InstaDeep
London, United Kingdom InstaDeep is an Artificial Intelligence company that makes use of AI to help businesses make complex decisions, better design their products and solve problems that are not easily solved with traditional approaches. InstaDeep was founded in 2014 and is based in London, United Kingdom. |
Buy | £362M |
| Category | Company |
|---|---|
| Founded | 2009 |
| Sector | Life Science |
| Employees | 184 |
| Revenue | 22M USD (2016) |
Kite Pharma, Inc. is a clinical-stage biopharmaceutical company engaged in the development of novel cancer immunotherapy products, with a primary focus on eACT designed to restore the immune system's ability to recognize and eradicate tumors. Kite Pharma was formed in 2009 and is based in Santa Monica, California.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector (Life Science) | 1 of 1 |
| Type (Divestiture) | 1 of 1 |
| State (Maryland) | 1 of 1 |
| Country (United States) | 1 of 1 |
| Year (2021) | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2017-12-07 |
Cell Design Labs
Emeryville, California, United States Cell Design Labs, Inc. is a biotherapeutics company pioneering breakthrough science to develop disruptive therapies for cancer and other devastating diseases. Cell Design Labs, Inc. was founded in 2015 and is based in San Emeryville, California. |
Buy | $567M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-12-20 |
Tmunity
Philadelphia, Pennsylvania, United States Tmunity is a private biotherapeutics company focused on saving and improving lives by delivering the full potential of next-generation T-cell immunotherapy to patients with devastating diseases. Tmunity was founded in 2015 and is based in Philadelphia, Pennsylvania. |
Buy | - |
